Eomesodermin+ CD4+ T cells are critical for curative immunotherapy outcomes.
Zhang P, Haeseleer F, Waltner OG, Gartlan KH, Bhise SS, Minnie SA, Adams RC, Yeh AC, Ensbey KS, Legg SRW, Sekiguchi T, Atilla E, Nemychenkov NS, Nelson EL, Joshi T, Liang EC, Hirayama AV, Abe K, Koyama M, Clouston AD, Gauthier J, Furlan SN, Hill GR.
Zhang P, et al. Among authors: bhise ss.
Immunity. 2025 Dec 9;58(12):3024-3039.e7. doi: 10.1016/j.immuni.2025.09.004. Epub 2025 Oct 2.
Immunity. 2025.
PMID: 41043413